Fundz
Back to SEC Filings
10-QHIGH RiskDETERIORATING

Regenerative Medical Technology Group Inc.

Filed: Jun 9, 2026 CIK: 0001760026
View original filing on SEC.gov

AI Executive Summary

AI-powered analysis of 10-Q filing content

Regenerative Medical Technology Group Inc. shows severe financial distress with a $35.6M stockholder deficit and massive debt burden of $40.6M against only $5M in assets. Despite 93% revenue growth to $2.6M, the company faces critical liquidity challenges with $38.2M in current liabilities versus $1.6M current assets, creating an unsustainable 24:1 liability ratio.

Red Flags Detected (6)

Stockholder deficit of $35.6M indicating technical insolvency

Massive accrued interest burden of $18M suggesting payment defaults

Current ratio of 0.04 indicating severe liquidity crisis

3 more red flags detected

Key Takeaways

Company is technically insolvent with liabilities exceeding assets by $35.6M

Revenue growth of 93% is being offset by proportional cost increases and massive interest burden

2 more takeaways

Filing Overview

Form TypeQuarterly Report (10-Q)
Filing DateJun 9, 2026
Risk LevelHIGH
TrendDETERIORATING
AI Confidence95%
Red Flags6

What This Means

High Risk Filing: This company is showing signs of financial stress or significant operational challenges.

Deteriorating Trend: Conditions are worsening compared to previous filings. This may create opportunities for service providers.

Quarterly Report: Interim filing with unaudited financial data for the quarter.

View Full Filing on SEC.govBrowse More Filings